About a decade ago, adult obesity rates of 35% were unheard of in the U.S
ArGLP-1 also reduced total mortality (HR 0.88, 95% CI 0.820.94, p = 0.0001) and hospital admission due to heart failure (HR 0.89, 95% CI 0.820.98, p = 0.013), all without increasing the risk of severe hypoglycemia, pancreatic problems or retinopathy.87 A recent post hoc analysis of CVOT with semaglutide has shown a gain in time free of cardiovascular disease of 1.7 years in those patients with CKD vs
Tschritter O, Fritsche A, Thamer C, et al
We plan to continue this work to help build a clearer understanding of these therapies and support providers and cancer survivors as the science continues to evolve, he said
See how patients across Mississippi are navigating their weight loss journey through InjectCos medically guided programs